Page 34 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 34

CHAPTER 1  The Etiology of Cancer  13



                                                                                             1    Branch A: median survival 2.83 mo
                    6            6                                                           0.8  Branch B: median survival 13.97 mo
                                                                                                   p value   0.009
                                                                                                   Chi-square   6.749
  VetBooks.ir  Greyhound  (p) 4 2  4 2                                                      Survival Probability  0.6
                                                                                             0.4
                   -log
            153 aff (89M+64F)
                                                                                             0.2
            114 unaff (65M+49F)
            105,934 SNPs
                0.9  0           0                                     Branch A   Branch B   0
                                                                                                   20
                                                                                                        40
                                                                                                     30
            A        0  1  2  3  4  5  D                                                      0  10  Time (months)  50  60
                                                                                           H
                    6            6
                   (p) 4         4
            Rottweiler  -log                                        Cluster 1  Genes
            80 aff (38M+42F)  2  2
            55 unaff (27M+28F)
            99,144 SNPs
                1.05  0          0
            B        0  1  2  3  4  5  E
                    4            4
                   (p)  3        3
            Irish wolfhound  -log  2  2                             Cluster 2  Genes
            28 aff (9M+19F)
            62 unaff (27M+35F)  1  1
            84,385 SNPs
                0.96  0          0  1  23 45 67 89 10  12  14161820222426283032343638X
                           3
                         2
            C        0  1 Expected -log p  4  5  F  Chromosome
                                                                   G     -3  -2  -1  0  1  2  3
                           • Fig. 1.7  Mixed model genome-wide association study corrects for population structure and identifies 33
                           osteosarcoma-associated loci, explaining a large fraction of phenotype variance. In each breed the QQ
                           plots show no evidence of stratification relative to the expected distribution, identifying nominal significance
                           at −log10p of 3.5 and the 95% empirically determined confidence intervals (dashed gray line) at −log10p of
                           (A) 5 in greyhounds, (B) 4 in Rottweilers, and (C) 3.7 in Irish wolfhounds (IWHs). In IWHs a plateau of SNPs
                           at P = 6.6 × 10 to 5 corresponds to a 1.65 Mb haplotype on chromosome 18, peaking at the gene GRB10.
                           (D) In greyhounds 14 loci have p > 0.0005, with 1 locus, on chromosome 11, exceeding 95% confidence
                           intervals (dashed lines). (E) In Rottweilers 15 and 6 loci are identified, (F) whereas only 4 and 2 loci are
                           identified in IWHs. (G) Unsupervised hierarchical clustering defines two osteosarcoma subtypes (Branch A
                           and Branch B), characterized by two reciprocal gene clusters (Gene Cluster 1 and Gene Cluster 2). Heat
                           map showing 282 differentially expressed transcripts (p ≤ 0.0068, mean average fold-change > 3). Heat
                           map colors represent median-centered fold change expression after log2 transformation (a quantitative
                           representation of the colors is provided in the scale at the bottom). Upregulated genes are shown in red,
                           and down regulated genes are shown in green. (H) Kaplan-Meier survival (KM) and log rank analysis of 21
                           dogs in the cohort with known survival outcomes show two clinically significant groups in canine osteo-
                           sarcoma. The toe bar defines groups for the KM analysis. The median survival time for dogs in Branch
                           A was ∼2.8 months, and the median survival time for dogs in Branch B was ∼14 months. (Reproduced
                           with permission. (A–F) from Karlsson EK, Sigurdsson S, Ivansson E, et al. Genome-wide analyses impli-
                           cate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B. Genome Biol.
                           2013 Dec 12;14(12):R132. https://doi.org/10.1186/gb-2013-14-12-r132. Fig. 1.2a–f. (G) and (H) from
                           Scott MC, Sarver AL, Gavin KJ, et al. Molecular subtypes of osteosarcoma identified by reducing tumor
                           heterogeneity through an interspecies comparative approach. Bone. 2011 Sep;49(3):356-367. https://doi.
                           org/10.1016/j.bone.2011.05.008. Figs. 1.1 and 1.6B, respectively.)



           Conclusion                                            in higher vertebrates is an inevitable consequence of evolution, 145
                                                                 improvements in our understanding of fundamental mechanisms
           The genetic basis of cancer is now beyond question. It is esti-  that account for malignant transformation and tumor progression
           mated that at least five to seven mutational events are required for   will allow the design of strategies to improve quality of life and
           overt malignant transformation. These events can occur through   outcomes for cancer patients. 
           multiple mechanisms, including heritable factors, environmen-
           tal elements, and/or stochastic DNA damage during cell repli-
           cation. Genomic instability seems to be necessary to establish a   SECTION B: CHEMICAL, PHYSICAL, AND
           pathogenic molecular program of convergent regulatory signaling   HORMONAL FACTORS
           pathways that cause clinical disease. Ultimately, a subpopulation
           endowed with metastatic properties that is drug resistant leads to
           death of the cancer patient. The rate and the flow of information   CAROLYN J. HENRY AND BRIAN K. FLESNER
           are such that we predict the coming decade will see additional
           transformational changes in our perception of how genes interact   In  1978  the  US  Congress ordered  the  development of the first
           with the macroenvironment at the organism level and with the   Report on Carcinogens (RoC), a document designed to educate
           microenvironment in tumors. Although it is possible that cancer   the public and health professionals on potential cancer hazards. The
   29   30   31   32   33   34   35   36   37   38   39